195 related articles for article (PubMed ID: 24204138)
1. Biodistribution of newly synthesized PHEA-based polymer-coated SPION in Sprague Dawley rats as magnetic resonance contrast agent.
Park J; Cho W; Park HJ; Cha KH; Ha DC; Choi YW; Lee HY; Cho SH; Hwang SJ
Int J Nanomedicine; 2013; 8():4077-89. PubMed ID: 24204138
[TBL] [Abstract][Full Text] [Related]
2. Biodistribution and Toxicity Assessment of Superparamagnetic Iron Oxide Nanoparticles In Vitro and In Vivo.
Yu Q; Xiong XQ; Zhao L; Xu TT; Bi H; Fu R; Wang QH
Curr Med Sci; 2018 Dec; 38(6):1096-1102. PubMed ID: 30536075
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution, kinetics, and biological fate of SPION microbubbles in the rat.
Barrefelt Å; Saghafian M; Kuiper R; Ye F; Egri G; Klickermann M; Brismar TB; Aspelin P; Muhammed M; Dähne L; Hassan M
Int J Nanomedicine; 2013; 8():3241-54. PubMed ID: 24023513
[TBL] [Abstract][Full Text] [Related]
4. Uptake and bioreactivity of charged chitosan-coated superparamagnetic nanoparticles as promising contrast agents for magnetic resonance imaging.
Kania G; Sternak M; Jasztal A; Chlopicki S; Błażejczyk A; Nasulewicz-Goldeman A; Wietrzyk J; Jasiński K; Skórka T; Zapotoczny S; Nowakowska M
Nanomedicine; 2018 Jan; 14(1):131-140. PubMed ID: 28939490
[TBL] [Abstract][Full Text] [Related]
5. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.
Unterweger H; Janko C; Schwarz M; Dézsi L; Urbanics R; Matuszak J; Őrfi E; Fülöp T; Bäuerle T; Szebeni J; Journé C; Boccaccini AR; Alexiou C; Lyer S; Cicha I
Int J Nanomedicine; 2017; 12():5223-5238. PubMed ID: 28769560
[TBL] [Abstract][Full Text] [Related]
6. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
7. Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging.
Lee H; Lee E; Kim DK; Jang NK; Jeong YY; Jon S
J Am Chem Soc; 2006 Jun; 128(22):7383-9. PubMed ID: 16734494
[TBL] [Abstract][Full Text] [Related]
8. Clustering superparamagnetic iron oxide nanoparticles produces organ-targeted high-contrast magnetic resonance images.
Hobson NJ; Weng X; Siow B; Veiga C; Ashford M; Thanh NT; Schätzlein AG; Uchegbu IF
Nanomedicine (Lond); 2019 May; 14(9):1135-1152. PubMed ID: 31050589
[No Abstract] [Full Text] [Related]
9. Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION-EGF) for targeting brain tumors.
Shevtsov MA; Nikolaev BP; Yakovleva LY; Marchenko YY; Dobrodumov AV; Mikhrina AL; Martynova MG; Bystrova OA; Yakovenko IV; Ischenko AM
Int J Nanomedicine; 2014; 9():273-87. PubMed ID: 24421639
[TBL] [Abstract][Full Text] [Related]
10. Ultrasmall superparamagnetic iron oxide (USPIO)-based liposomes as magnetic resonance imaging probes.
Frascione D; Diwoky C; Almer G; Opriessnig P; Vonach C; Gradauer K; Leitinger G; Mangge H; Stollberger R; Prassl R
Int J Nanomedicine; 2012; 7():2349-59. PubMed ID: 22661890
[TBL] [Abstract][Full Text] [Related]
11. Size-isolation of superparamagnetic iron oxide nanoparticles improves MRI, MPI and hyperthermia performance.
Dadfar SM; Camozzi D; Darguzyte M; Roemhild K; Varvarà P; Metselaar J; Banala S; Straub M; Güvener N; Engelmann U; Slabu I; Buhl M; van Leusen J; Kögerler P; Hermanns-Sachweh B; Schulz V; Kiessling F; Lammers T
J Nanobiotechnology; 2020 Jan; 18(1):22. PubMed ID: 31992302
[TBL] [Abstract][Full Text] [Related]
12. Exploring a new SPION-based MRI contrast agent with excellent water-dispersibility, high specificity to cancer cells and strong MR imaging efficacy.
Ma X; Gong A; Chen B; Zheng J; Chen T; Shen Z; Wu A
Colloids Surf B Biointerfaces; 2015 Feb; 126():44-9. PubMed ID: 25543982
[TBL] [Abstract][Full Text] [Related]
13. Increased transverse relaxivity in ultrasmall superparamagnetic iron oxide nanoparticles used as MRI contrast agent for biomedical imaging.
Mishra SK; Kumar BS; Khushu S; Tripathi RP; Gangenahalli G
Contrast Media Mol Imaging; 2016 Sep; 11(5):350-361. PubMed ID: 27230705
[TBL] [Abstract][Full Text] [Related]
14. Metabolic pathway and distribution of superparamagnetic iron oxide nanoparticles: in vivo study.
Schlachter EK; Widmer HR; Bregy A; Lönnfors-Weitzel T; Vajtai I; Corazza N; Bernau VJ; Weitzel T; Mordasini P; Slotboom J; Herrmann G; Bogni S; Hofmann H; Frenz M; Reinert M
Int J Nanomedicine; 2011; 6():1793-800. PubMed ID: 21980242
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetics, tissue distribution and magnetic resonance's response characterstics of folic acid-O-carboxymethyl chitosan ultrasmall superparamagnetic iron oxide nanoparticles in mice and rats].
Gao WH; Liu ST; Fan CX; Qi LY; Chen ZL
Yao Xue Xue Bao; 2011 Jul; 46(7):845-51. PubMed ID: 22010356
[TBL] [Abstract][Full Text] [Related]
16. New strategies to prolong the in vivo life span of iron-based contrast agents for MRI.
Antonelli A; Sfara C; Battistelli S; Canonico B; Arcangeletti M; Manuali E; Salamida S; Papa S; Magnani M
PLoS One; 2013; 8(10):e78542. PubMed ID: 24223101
[TBL] [Abstract][Full Text] [Related]
17. Diffusion and clearance of superparamagnetic iron oxide nanoparticles infused into the rat striatum studied by MRI and histochemical techniques.
Wang FH; Kim DK; Yoshitake T; Johansson SM; Bjelke B; Muhammed M; Kehr J
Nanotechnology; 2011 Jan; 22(1):015103. PubMed ID: 21135466
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of Iron Oxide-Based Contrast Agents in Rabbit Atherosclerotic Plaques in Relation to Plaque Age and Vulnerability Features.
Sekita A; Unterweger H; Berg S; Ohlmeyer S; Bäuerle T; Zheng KH; Coolen BF; Nederveen AJ; Cabella C; Rossi S; Stroes ESG; Alexiou C; Lyer S; Cicha I
Int J Nanomedicine; 2024; 19():1645-1666. PubMed ID: 38406599
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous evaluation of vascular morphology, blood volume and transvascular permeability using SPION-based, dual-contrast MRI: imaging optimization and feasibility test.
Kwon HJ; Shim WH; Cho G; Cho HJ; Jung HS; Lee CK; Lee YS; Baek JH; Kim EJ; Suh JY; Sung YS; Woo DC; Kim YR; Kim JK
NMR Biomed; 2015 Jun; 28(6):624-32. PubMed ID: 25865029
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
